Old Web
English
Sign In
Acemap
>
authorDetail
>
Yukiko Ishikawa-Takemura
Yukiko Ishikawa-Takemura
Biochemistry
Diabetes mellitus
Insulin
Endocrinology
Internal medicine
6
Papers
369
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Design, synthesis, and structure–activity relationships of a series of 4-benzyl-5-isopropyl-1H-pyrazol-3-yl β-d-glycopyranosides substituted with novel hydrophilic groups as highly potent inhibitors of sodium glucose co-transporter 1 (SGLT1)
2013
Bioorganic & Medicinal Chemistry
Nobuhiko Fushimi
Hirotaka Teranishi
Kazuo Shimizu
Shigeru Yonekubo
Kohsuke Ohno
Takashi Miyagi
Fumiaki Itoh
Toshihide Shibazaki
Masaki Tomae
Yukiko Ishikawa-Takemura
Takeshi Nakabayashi
Noboru Kamada
Yuji Yamauchi
Susumu Kobayashi
Masayuki Isaji
Show All
Source
Cite
Save
Citations (13)
KGA-2727, a Novel Selective Inhibitor of a High-Affinity Sodium Glucose Cotransporter (SGLT1), Exhibits Antidiabetic Efficacy in Rodent Models
2012
Journal of Pharmacology and Experimental Therapeutics
Toshihide Shibazaki
Masaki Tomae
Yukiko Ishikawa-Takemura
Nobuhiko Fushimi
Fumiaki Itoh
Mitsuhiko Yamada
Masayuki Isaji
Show All
Source
Cite
Save
Citations (58)
Structure-activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia.
2012
Bioorganic & Medicinal Chemistry
Nobuhiko Fushimi
Hideki Fujikura
Hiroaki Shiohara
Hirotaka Teranishi
Kazuo Shimizu
Shigeru Yonekubo
Kohsuke Ohno
Takashi Miyagi
Fumiaki Itoh
Toshihide Shibazaki
Masaki Tomae
Yukiko Ishikawa-Takemura
Takeshi Nakabayashi
Noboru Kamada
Tomonaga Ozawa
Susumu Kobayashi
Masayuki Isaji
Show All
Source
Cite
Save
Citations (15)
Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-Ay mice
2009
European Journal of Pharmacology
Kenji Katsuno
Yoshikazu Fujimori
Yukiko Ishikawa-Takemura
Masayuki Isaji
Show All
Source
Cite
Save
Citations (33)
Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats
2009
European Journal of Pharmacology
Yoshikazu Fujimori
Kenji Katsuno
Kazuma Ojima
Ikumi Nakashima
Shigeru Nakano
Yukiko Ishikawa-Takemura
Hiroshi Kusama
Masayuki Isaji
Show All
Source
Cite
Save
Citations (67)
1